TAIM
TMO icon

TD Ameritrade Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

TD Ameritrade Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39
Closed -$20K – 446
2023
Q2 		$20K Sell
39
-10
-20% -$5.4K ﹤0.01% 283
2023
Q1 		$28K Sell
49
-26
-35% -$14.7K ﹤0.01% 275
2022
Q4 		$41K Sell
75
-55
-42% -$29.1K ﹤0.01% 266
2022
Q3 		$66K Sell
130
-71
-35% -$39.7K ﹤0.01% 263
2022
Q2 		$109K Sell
201
-63
-24% -$34.7K ﹤0.01% 251
2022
Q1 		$156K Buy
264
+37
+16% +$21.3K ﹤0.01% 254
2021
Q4 		$151K Buy
227
+38
+20% +$23.7K ﹤0.01% 257
2021
Q3 		$83K Sell
189
-8
-4% -$4.39K ﹤0.01% 279
2021
Q2 		$99K Buy
197
+27
+16% +$12.7K ﹤0.01% 282
2021
Q1 		$79K Hold
170
– – ﹤0.01% 293
2020
Q4 		$79K Sell
170
-19
-10% -$8.91K ﹤0.01% 293
2020
Q3 		$83K Buy
189
+9
+5% +$3.72K ﹤0.01% 279
2020
Q2 		$65K Buy
180
+5
+3% +$1.68K ﹤0.01% 286
2020
Q1 		$50K Sell
175
-20
-10% -$6.31K ﹤0.01% 293
2019
Q4 		$63K Buy
195
+125
+179% +$37.9K ﹤0.01% 293
2019
Q3 		$20K Buy
70
+44
+169% +$12.6K ﹤0.01% 379
2019
Q2 		$8K Buy
26
+11
+73% +$3.03K ﹤0.01% 445
2019
Q1 		$4K Sell
15
-25
-63% -$6.22K ﹤0.01% 477
2018
Q4 		$9K Sell
40
-1
-2% -$235 ﹤0.01% 368
2018
Q3 		$10K Buy
+41
New +$9.43K ﹤0.01% 333

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

TD Ameritrade Investment Management's TMO Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 39 shares — an estimated $20K sold.

TD Ameritrade Investment Management first reported a position in TMO in Q3 2018 and held it in 20 quarters. The position peaked at $156K in Q1 2022. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 39 Thermo Fisher Scientific shares in Q3 2023, an estimated $20K.
  • TD Ameritrade Investment Management first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 20 quarters.
  • TD Ameritrade Investment Management's Thermo Fisher Scientific position peaked at $156K in Q1 2022.
  • 2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.